RA
OMCL icon

Royce & Associates’s Omnicell OMCL Stock Holding History

Royce & Associates’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,654
Closed -$256K – 798
2025
Q4 		$256K Sell
5,654
-13,763
-71% -$504K ﹤0.01% 739
2025
Q3 		$591K Buy
19,417
+260
+1% +$7.99K 0.01% 699
2025
Q2 		$563K Sell
19,157
-260
-1% -$7.78K 0.01% 707
2025
Q1 		$679K Hold
19,417
– – 0.01% 710
2024
Q4 		$864K Buy
19,417
+820
+4% +$36.8K 0.01% 737
2024
Q3 		$811K Buy
+18,597
New +$701K 0.01% 752

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Royce & Associates's OMCL Position: Q1 2026 in Review

Royce & Associates sold out of Omnicell (OMCL) in Q1 2026, closing a stake of 5,654 shares — an estimated $256K sold.

Royce & Associates first reported a position in OMCL in Q3 2024 and held it in 6 quarters. The position peaked at $864K in Q4 2024. 273 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Royce & Associates reported no remaining Omnicell position as of Q1 2026 after selling out during the quarter.
  • Royce & Associates sold 5,654 Omnicell shares in Q1 2026, an estimated $256K.
  • Royce & Associates first reported a position in Omnicell in Q3 2024 and held it in 6 quarters.
  • Royce & Associates's Omnicell position peaked at $864K in Q4 2024.
  • 273 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.